eurocognitive testing in children with ADHD
Completed
- Conditions
- ADHD10009841
- Registration Number
- NL-OMON32584
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
• Written informed consent from parents having parental responsibility or from the legal guardian. In the case of a child aged 12 years the written informed consent of the child is needed in addition to that of parents having responsibility/legal guardian;
• Aged 8-12 years;
• Able to communicate with the investigator in Dutch;
• Confirmed DSM IV diagnosis of ADHD (Based on examination by a psychiatrist or pediatrician);
• Classifying as clinical ADHD on the AVL(*ADHD Vragenlijst*);
• Currently receiving treatment with (immediate or sustained release) methylphenidate
Exclusion Criteria
Use of drugs other than methylphenidate with known psychotropic effects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- Results of Neurocognitive tasks:<br /><br><br /><br>- Stroop color-word task<br /><br>- Adaptive tracking<br /><br>- Smooth eye pursuit<br /><br>- Saccadic Eye movements<br /><br>- Finger tapping<br /><br>- Body sway<br /><br>- Choice Reaction Task<br /><br><br /><br>- Electro-encephalograms<br /><br><br /><br>- Methylphenidate concentrations in saliva<br /><br><br /><br>- Cardiovascular parameters (blood pressure and heart rate)<br /><br><br /><br>- Evaluation of clinical treatment effect using the *ADHD Vragenlijst*<br /><br><br /><br>- Results of a short questionnaire taken after completion of the Neurocognitive<br /><br>tasks.</p><br>
- Secondary Outcome Measures
Name Time Method <p>NA</p><br>